| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9346364 | Ophthalmology | 2005 | 10 Pages |
Abstract
The maximum tolerated single dose of ranibizumab in neovascular AMD patients was 500 μg. Single intravitreal injections of ranibizumab up to a dose of 500 μg were safe and well tolerated in this small group of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Philip J. MD, PhD, Steven D. MD, Mark S. MD, Joan W. MD, Julia A. MD, James D. PhD, William L. MD, Naveed MD, PhD,